Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PROCTER & GAMBLE HEALTH - Comparison Results

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PROCTER & GAMBLE HEALTH DR. DATSONS LABS/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x -10.9 59.5 - View Chart
P/BV x 0.2 7.3 2.2% View Chart
Dividend Yield % 0.0 6.5 -  

Financials

 DR. DATSONS LABS   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PROCTER & GAMBLE HEALTH
Dec-18
DR. DATSONS LABS/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs1263,549 3.5%   
Low Rs311,301 2.4%   
Sales per share (Unadj.) Rs133.0511.4 26.0%  
Earnings per share (Unadj.) Rs0.261.3 0.2%  
Cash flow per share (Unadj.) Rs6.674.0 8.9%  
Dividends per share (Unadj.) Rs0440.00 0.0%  
Dividend yield (eoy) %018.1 0.0%  
Book value per share (Unadj.) Rs128.8927.8 13.9%  
Shares outstanding (eoy) m31.6616.60 190.7%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.7 12.4%   
Avg P/E ratio x516.139.6 1,304.4%  
P/CF ratio (eoy) x11.832.8 36.1%  
Price / Book Value ratio x0.62.6 23.2%  
Dividend payout %0717.9 0.0%   
Avg Mkt Cap Rs m2,47740,257 6.2%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m561,313 4.3%   
Avg. sales/employee Rs ThNM7,486.7-  
Avg. wages/employee Rs ThNM1,157.6-  
Avg. net profit/employee Rs ThNM897.2-  
INCOME DATA
Net Sales Rs m4,2118,490 49.6%  
Other income Rs m79244 32.3%   
Total revenues Rs m4,2898,734 49.1%   
Gross profit Rs m5691,482 38.4%  
Depreciation Rs m204211 96.8%   
Interest Rs m4300-   
Profit before tax Rs m131,514 0.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m066 0.0%   
Tax Rs m6563 1.1%   
Profit after tax Rs m51,017 0.5%  
Gross profit margin %13.517.5 77.4%  
Effective tax rate %48.037.1 129.3%   
Net profit margin %0.112.0 1.0%  
BALANCE SHEET DATA
Current assets Rs m6,85215,343 44.7%   
Current liabilities Rs m6,7111,960 342.3%   
Net working cap to sales %3.3157.6 2.1%  
Current ratio x1.07.8 13.0%  
Inventory Days Days16149 330.0%  
Debtors Days Days31828 1,119.5%  
Net fixed assets Rs m3,6731,209 303.7%   
Share capital Rs m317166 190.7%   
"Free" reserves Rs m3,76115,235 24.7%   
Net worth Rs m4,07815,401 26.5%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63317,595 71.8%  
Interest coverage x1.0NM-  
Debt to equity ratio x0.40-  
Sales to assets ratio x0.30.5 69.1%   
Return on assets %3.45.8 59.6%  
Return on equity %0.16.6 1.8%  
Return on capital %7.710.3 74.8%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m9641,636 58.9%   
Fx outflow Rs m6074,368 13.9%   
Net fx Rs m357-2,732 -13.1%   
CASH FLOW
From Operations Rs m1,345-1,304 -103.1%  
From Investments Rs m-2,25612,697 -17.8%  
From Financial Activity Rs m-1,200-301 399.3%  
Net Cashflow Rs m-2,11111,093 -19.0%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 0.0 18.2 -  
FIIs % 1.4 1.0 135.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 29.1 323.4%  
Shareholders   20,807 28,591 72.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   J.B.CHEMICALS  SUVEN LIFE SCIENCES  CIPLA  CADILA HEALTHCARE  VENUS REMEDIES  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex and Nifty Fell Over 1% Today(Closing)

Indian share markets witnessed heavy selling pressure today, pausing the record rally, with all sectors barring telecom, reeling under pressure.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY21); Net Profit Up 57.0% (Quarterly Result Update)

Aug 31, 2020 | Updated on Aug 31, 2020

For the quarter ended June 2020, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 692 m (up 57.0% YoY). Sales on the other hand came in at Rs 6 bn (up 171.6% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS